BOLT Earnings

Quarterly EPS
$-7.93
Q3 2024
$-2.88
Q4 2024
$-5.76
Q1 2025
$-4.46
Q2 2025
$-3.72
Q3 2025
$-3.84
Q4 2025
$-4.31
Q1 2026
$-4.57
Q2 2026
Latest Revenue5.0K
Latest Net Income-7720000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$4.575.0K-7720000-99.7%-2.5%
Q1 2026-$4.3126.0K-7244000-97.9%+25.2%
Q4 2025-$3.842.5M-6631000-33.3%
Q3 2025-$3.722.2M-7144000+90.1%+53.1%
Q2 2025-$4.461.8M-8561000+41.5%+59.9%
Q1 2025-$5.761.2M-11040000-76.8%-2.9%
Q4 2024-$2.880-15936000-100.0%+69.5%
Q3 2024-$7.931.1M-15176000-54.9%+7.8%
Q2 2024-$11.121.3M-21195000
Q1 2024-$5.605.3M-10811000
Q4 2023-$9.442.1M-17903000
Q3 2023-$8.602.5M-16257000
Bolt Biotherapeutics (BOLT) — Earnings